secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axogen, Inc. (AXGN)
CIK:        0000805928
Form:       8-K/A
Filed at:   2026-09-10T20:55:04+00:00
Accession:  0001628280-26-061393
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axogen files merger agreement with BioCircuit Technologies; terms not disclosed
-------------------------------------------------------------------------------

- Axogen entered into a merger agreement with BioCircuit Technologies on September 9, 2026, with Omega Merger Sub as merger sub.
- Agreement filed as Exhibit 2.1; Michelle Jarrard named representative for BioCircuit equityholders.
- Corrected investor presentation dated September 10, 2026 furnished as Exhibit 99.2.
- No deal value, premium, or closing conditions disclosed in the filing text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/805928/000162828026061393/0001628280-26-061393-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/805928/000162828026061393/axgn-20260909.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-061393

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer